Jingzhu Zhou

Follow

Generating author description...

Common Coauthors
Coauthor Papers Together
Stephen L. George 1
Ting Wang 1
Xiaofei Wang 1
Commonly Cited References
Action Title Year Authors # of times referenced
+ Clinical Trial Designs for Predictive Marker Validation in Cancer Treatment Trials 2005 Daniel J. Sargent
Barbara A. Conley
Carmen J. Allegra
Laurence Collette
1
+ PDF Chat A Generalized Estimator of the Attributable Benefit of an Optimal Treatment Regime 2009 Jason Brinkley
Anastasios A. Tsiatis
Kevin J. Anstrom
1
+ PDF Chat An Approach to Evaluating and Comparing Biomarkers for Patient Treatment Selection 2014 Holly Janes
Marshall Brown
Ying Huang
Margaret S. Pepe
1
+ PDF Chat Estimation of AUC or Partial AUC Under Test-Result-Dependent Sampling 2012 Xiaofei Wang
Junling Ma
Stephen L. George
Haibo Zhou
1
+ PDF Chat Improving cost‐effectiveness of epidemiological studies via designed missingness strategies 2010 Warren Strauss
Louise Ryan
Michele Morara
Nicole Iroz‐Elardo
Mark D. Davis
Matthew Cupp
Marcia Nishioka
James J. Quackenboss
Warren Galke
HalĂ»k Özkaynak
1
+ Enrichment design with patient population augmentation 2015 Bo Yang
Yijie Zhou
Lanju Zhang
Lu Cui
1
+ Optimal design for epidemiological studies subject to designed missingness 2007 Michele Morara
Louise Ryan
E. Andrés Houseman
Warren Strauss
1
+ PDF Chat Design and Inference for Cancer Biomarker Study with an Outcome and Auxiliary‐Dependent Subsampling 2009 Xiaofei Wang
Haibo Zhou
1
+ PDF Chat Clinical Trial Designs for Predictive Biomarker Validation: Theoretical Considerations and Practical Challenges 2009 Sumithra J. Mandrekar
Daniel J. Sargent
1
+ PDF Chat Randomized Clinical Trials With Biomarkers: Design Issues 2010 Boris Freidlin
Lisa M. McShane
Edward L. Korn
1
+ Trial Designs for Personalizing Cancer Care: A Systematic Review and Classification 2013 Parvin Tajik
Aleiko H. Zwinderman
Ben W. Mol
Patrick M. Bossuyt
1
+ PDF Chat ROC curve estimation under test-result-dependent sampling 2012 Xiangyu Wang
JinHua Ma
Stephen L. George
1
+ PDF Chat Measuring the Performance of Markers for Guiding Treatment Decisions 2011 Holly Janes
Margaret S. Pepe
Patrick M. Bossuyt
William E. Barlow
1
+ PDF Chat Evaluating the Efficiency of Targeted Designs for Randomized Clinical Trials 2004 Richard Simon
Aboubakar Maitournam
1
+ Comparison of Statistical Analysis Plans in Randomize-All Phase III Trials with a Predictive Biomarker 2014 Shigeyuki Matsui
Yuki Choai
Takahiro Nonaka
1
+ PDF Chat Statistical and Practical Considerations for Clinical Evaluation of Predictive Biomarkers 2013 M.-Y. C. Polley
Boris Freidlin
Edward L. Korn
Barbara A. Conley
Jeffrey S. Abrams
Lisa M. McShane
1